動物模型市場規模、佔有率和成長分析（按動物類型、技術、應用、最終用戶和地區）- 產業預測 2025-2032

2023 年全球動物模型市場規模價值為 28 億美元，預計將從 2024 年的 30.3 億美元成長到 2032 年的 56.4 億美元，預測期間（2025-2032 年）的複合年成長率為 8.1%。

動物模型市場對於研究癌症和心血管疾病等慢性疾病、尋求準確代表人體生理學的研究人員至關重要。該市場的成長是由複雜健康問題的不斷增加和個人化醫療的需求所推動的。基因轉殖小鼠等基因改造模型的進步使得人們能夠詳細研究基因功能和疾病機制。此外，以患者為來源的動物模型的興起正在推動精準醫療的趨勢。儘管存在道德考慮和替代技術等挑戰，市場仍然蓬勃發展，並為藥物開發和科學理解做出貢獻。預計美國動物模型市場在未來的預測期內將保持持續的複合年成長率，顯示未來具有很高的成長潛力。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

動物模型市場規模（按動物類型和複合年成長率） (2025-2032)

• 市場概況
• 老鼠
• 老鼠
• 天竺鼠
• 兔子
• 倉鼠
• 其他

動物模型市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• CRISPR
• 顯微注射
• 胚胎幹細胞注射

動物模型市場規模（按應用和複合年成長率） (2025-2032)

• 市場概況
• 研究與開發
• 生產
• 品管

動物模型市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 研究組織
• 教育機構
• 製藥公司
• 合約研究組織

動物模型市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Charles River Laboratories（USA）
• The Jackson Laboratory（USA）
• Janvier Labs（France）
• Genoway（France）
• Ozgene（Australia）
• Hera Biolabs（UK）
• Crown Bioscience（USA）
• Inotiv（USA）
• Transgenic（Japan）
• JSR Life Sciences（Japan）
• Biocytogen（China）
• Harbour BioMed（China）
• Cyagen Biosciences（China）
• Horizon Discovery（UK）
• Cellectis（France）
• CRISPR Therapeutics（Switzerland）
• Editas Medicine（USA）
• Intellia Therapeutics（USA）

結論和建議

Global Animal Model Market size was valued at USD 2.8 billion in 2023 and is poised to grow from USD 3.03 billion in 2024 to USD 5.64 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The animal model market is essential for researchers seeking accurate representations of human physiology to study chronic diseases, including cancer and cardiovascular disorders. Growth in this market is driven by the increasing incidence of complex health issues and the demand for personalized medicine. Advancements in genetically modified models, like transgenic mice, enable detailed investigations into gene functions and disease mechanisms. Additionally, the rise of patient-derived animal models supports the trend toward precision medicine. Despite challenges such as ethical considerations and alternative technologies, the market continues to thrive, contributing to drug development and scientific understanding. The US animal model market is expected to maintain a sustainable CAGR in the upcoming forecast period, indicating strong future growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Model Market Segments Analysis

Global Animal Model Market is segmented by Animal Type, Technology, Application, End User and region. Based on Animal Type, the market is segmented into Mice, Rat, Guinea Pigs, Rabbits, Hamsters and Others. Based on Technology, the market is segmented into CRISPR, Microinjection and Embryonic Stem Cell Injection. Based on Application, the market is segmented into Research and Development, Production and Quality Control. Based on End User, the market is segmented into Research Institutes, Educational Institutes, Pharmaceutical Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Model Market

The Global Animal Model market is significantly driven by innovations in genomics and precision medicine, as there is a rising demand for animal models that can closely mimic individual patient characteristics and responses to therapies. Both researchers and pharmaceutical companies are actively employing these models to explore specific genetic variations and create targeted treatments. A notable example is the emergence of patient-derived xenograft (PDX) models, which involve implanting patient tumor samples into animals for efficacy testing, gaining traction in 2022. This approach enables the assessment of treatment effectiveness tailored to each patient, thereby fueling the need for advanced animal models in the realm of personalized medicine.

Restraints in the Global Animal Model Market

While the animal model market has experienced notable progress, ethical issues and concerns regarding animal welfare continue to act as significant barriers as of 2022. The employment of animals in research invites ethical dilemmas and fosters discussions about their humane treatment. Stricter animal welfare regulations and heightened public scrutiny, especially in regions with rigorous standards, have intensified the examination of animal model usage. These ethical considerations and regulatory frameworks not only hinder market growth but also stimulate efforts to innovate and adopt alternative technologies and methodologies that could potentially replace animal models in research, shaping the future of the industry.

Market Trends of the Global Animal Model Market

In 2023, the Global Animal Model market continues to embrace a significant trend towards humanized and translational models, reflecting a heightened commitment to enhancing the relevance of research to human health. This shift involves the integration of human cells, tissues, and genetic modifications into animal models, enabling more accurate mimicking of human physiology and disease mechanisms. Notably, advancements such as humanized mice with functional human immune systems facilitate deeper exploration of complex conditions like immune-related diseases and the efficacy of novel immunotherapies. This evolving focus underscores the industry's objective to improve predictive outcomes in drug development and disease research, positioning humanized models as pivotal in the quest for translational success.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Animal Model Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

Global Animal Model Market Size by Technology & CAGR (2025-2032)

• Market Overview
• CRISPR
• Microinjection
• Embryonic Stem Cell Injection

Global Animal Model Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research and Development
• Production
• Quality Control

Global Animal Model Market Size by End User & CAGR (2025-2032)

• Market Overview
• Research Institutes
• Educational Institutes
• Pharmaceutical Companies
• Contract Research Organizations

Global Animal Model Market Size & CAGR (2025-2032)

• North America (Animal Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Animal Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Animal Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Animal Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Animal Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janvier Labs (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genoway (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ozgene (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hera Biolabs (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotiv (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transgenic (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JSR Life Sciences (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harbour BioMed (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CRISPR Therapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations